66 related articles for article (PubMed ID: 15517140)
1. [Department and patient management in radiotherapy. The Freiburg model].
Heinemann F; Röhner F; Schmucker M; Bruggmoser G; Henne K; Grosu AL; Frommhold H
Strahlenther Onkol; 2009 Mar; 185(3):143-54. PubMed ID: 19330290
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
3. [Principles of PET/CT and clinical application].
Bockisch A; Beyer T; Antoch G; Veit P; Müller S; Pink R; Rosenbaum S; Kühl H
Radiologe; 2004 Nov; 44(11):1045-54. PubMed ID: 15517140
[TBL] [Abstract][Full Text] [Related]
4. [PET/CT in lymphoma patients].
Steinert HC
Radiologe; 2004 Nov; 44(11):1060-7. PubMed ID: 15517141
[TBL] [Abstract][Full Text] [Related]
5. [PET-CT interventional tumour therapy].
Herzog P; Scher B; Helmberger T; Hahn K; Reiser MF; Becker CR
Radiologe; 2004 Nov; 44(11):1088-95. PubMed ID: 15526183
[TBL] [Abstract][Full Text] [Related]
6. [PET/CT imaging in head and neck tumors].
Rödel R; Straehler-Pohl HJ; Palmedo H; Reichmann K; Jaeger U; Reinhardt MJ; Biersack HJ
Radiologe; 2004 Nov; 44(11):1055-9. PubMed ID: 15517137
[TBL] [Abstract][Full Text] [Related]
7. Dual-modality PET/CT instrumentation-today and tomorrow.
Lonsdale MN; Beyer T
Eur J Radiol; 2010 Mar; 73(3):452-60. PubMed ID: 20096520
[TBL] [Abstract][Full Text] [Related]
8. [PET/CT for colorectal and hepatic tumors].
Stollfuss J; Wieder H; Rummeny E; Schwaiger M
Radiologe; 2004 Nov; 44(11):1068-78. PubMed ID: 15517139
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls.
Bockisch A; Beyer T; Antoch G; Freudenberg LS; Kühl H; Debatin JF; Müller SP
Mol Imaging Biol; 2004; 6(4):188-99. PubMed ID: 15262234
[TBL] [Abstract][Full Text] [Related]
10. Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.
Freudenberg LS; Antoch G; Görges R; Knust J; Pink R; Jentzen W; Debatin JF; Brandau W; Bockisch A; Stattaus J
Eur Radiol; 2003 Dec; 13 Suppl 4():L19-23. PubMed ID: 15018161
[TBL] [Abstract][Full Text] [Related]
11. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
[TBL] [Abstract][Full Text] [Related]
12. Acquisition protocol considerations for combined PET/CT imaging.
Beyer T; Antoch G; Müller S; Egelhof T; Freudenberg LS; Debatin J; Bockisch A
J Nucl Med; 2004 Jan; 45 Suppl 1():25S-35S. PubMed ID: 14736833
[TBL] [Abstract][Full Text] [Related]
13. PET/CT today and tomorrow.
Townsend DW; Carney JP; Yap JT; Hall NC
J Nucl Med; 2004 Jan; 45 Suppl 1():4S-14S. PubMed ID: 14736831
[TBL] [Abstract][Full Text] [Related]
14. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
Antoch G; Vogt FM; Freudenberg LS; Nazaradeh F; Goehde SC; Barkhausen J; Dahmen G; Bockisch A; Debatin JF; Ruehm SG
JAMA; 2003 Dec; 290(24):3199-206. PubMed ID: 14693872
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
